FOXO1 and endothelial dysfunction: AdipoRon modulates AdipoR1/AdipoR2 expressions via the pAMPK-FoxO1-dependent pathway in HCMs; activation of associated primary signaling pathways enhances downstream target molecules involved in lipid metabolism, mitochondrial biogenesis, and endothelial dysfunction